Vitamin D deficiency is associated with the presence and severity of diabetic retinopathy in type 2 Diabetes Mellitus by Alcubierre Calvo, Núria et al.
Research Article
Vitamin D Deficiency Is Associated with the Presence and
Severity of Diabetic Retinopathy in Type 2 Diabetes Mellitus
Nuria Alcubierre,1 Joan Valls,2 Esther Rubinat,1,3 Gonzalo Cao,4 Aureli Esquerda,4
Alicia Traveset,5 Minerva Granado-Casas,1 Carmen Jurjo,5 and Didac Mauricio1,6
1Biomedical Research Institute of Lleida, University of Lleida, Rovira Roure 80, 25198 Lleida, Spain
2Biostatistics & Epidemiology Unit, Biomedical Research Institute of Lleida, University of Lleida, Rovira Roure 80, 25198 Lleida, Spain
3Department of Endocrinology & Nutrition, University Hospital Arnau de Vilanova, Rovira Roure 80, 25198 Lleida, Spain
4Department of Laboratory Medicine, University Hospital Arnau de Vilanova, Rovira Roure 80, 25198 Lleida, Spain
5Department of Ophthalmology, University Hospital Arnau de Vilanova, Rovira Roure 80, 25198 Lleida, Spain
6Department of Endocrinology & Nutrition, Health Sciences Research Institute and University Hospital Germans Trias i Pujol,
Carretera Canyet S/N, 08916 Badalona, Spain
Correspondence should be addressed to Didac Mauricio; didacmauricio@gmail.com
Received 14 December 2014; Revised 3 May 2015; Accepted 4 May 2015
Academic Editor: Patrizio Tatti
Copyright © 2015 Nuria Alcubierre et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
There is very few evidences on the role of vitamin D in the development of diabetic retinopathy. The aim of the current study was
to explore whether there is an association of vitamin D status and diabetic retinopathy in type 2 diabetes. Two groups of patients
were selected: 139 and 144 patients with and without retinopathy, respectively, as assessed by an experienced ophthalmologist.
Subjects with advanced late diabetic complications were excluded to avoid confounding biases. 25-Hydroxy-vitaminD
3
(25(OH)D)
concentrations and vitaminD deficiency were associated with the presence of diabetic retinopathy. Additionally, patients withmore
advanced stages of retinopathy (grades 2–4) had lower concentrations of 25(OH)D and were more frequently vitamin D deficient
as compared with patients not carrying this eye complication. In conclusion, our study confirms the association of vitamin D
deficiency with the presence and severity of diabetic retinopathy in type 2 diabetes. Further experimental and prospective studies
on this issue are clearly warranted.
1. Introduction
Vitamin D deficiency is highly prevalent worldwide [1].
Serum 25-hydroxy-vitamin D
3
(25(OH)D) is a better indi-
cator of vitamin D sufficiency than the active hormone,
that is, 1,25-dihydroxy-vitamin D
3
[2]. Therefore, the serum
concentration of 25(OH)D is widely accepted as a good
indicator of the status of vitamin D in a given subject.
The main biological actions of vitamin D include the
maintenance of mineral homeostasis and the regulation
of bone remodeling [1]. However, there is a vast array
of pleiotropic actions of this vitamin that were already
recognized more than two decades ago [2]. This area of
investigation led to improved knowledge on the potential role
of vitamin D on glucose homeostasis and in the pathogenesis
of type 2 diabetes. Multiple studies have previously shown
that vitamin D deficiency is highly prevalent in type 1 and
type 2 diabetes [3]. Additionally, there is a growing interest
on the potential role of vitamin in the development of diabetic
micro- and macroangiopathic complications [4, 5].
Further, the potential role of vitamin D in the develop-
ment of diabetic retinopathy has been a matter of specific
interest in recent years. There is some experimental evidence
on the preventive effect of vitamin D in the development
of diabetic retinopathy in a rodent model [6]. However, the
evidence behind the involvement of vitaminD is really scarce.
A recent PubMed search (accessed on April 24, 2015), with
the use of terms “vitamin D” and “diabetic retinopathy,”
yielded only 31 publications. Thus, other studies have already
addressed the question of the potential implication of vitamin
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D in the pathogenesis of diabetic retinopathy [7–15]. Among
these studies there were only 7 publications that included the
study of the potential association between vitamin D and the
presence of this microangiopathic complication in patients
with type 2 diabetes [7–13]. Because of the cross-sectional
design of these studies, only an association between lower
serum 25(OH)D concentrations and/or vitamin D deficiency
and the presence of diabetic retinopathy in type 2 diabetes
has been described. Additionally, there are also conflicting
data on the role of vitamin D in retinopathy in type 1 diabetes
[4, 14, 15]. In a cross-sectional study, Shimo et al. showed an
association between vitaminD deficiency and the presence of
diabetic retinopathy in a small sample of young adults with
type 1 diabetes [15]. However, the only prospective study in
this field was performed also in type 1 diabetes and did not
confirm vitamin D deficiency as a risk factor for diabetic
retinopathy or any other microvascular complications [14].
To our knowledge, there are no data on the possible
association of vitamin D and diabetic retinopathy in type
2 diabetic patients in any European population, including
Spain. Thus, the primary objective of the current study was
to assess whether there is an association of vitamin D status
and diabetic retinopathy in type 2 diabetes. Additionally, as
a secondary outcome, we aimed to assess the association of
vitamin D concentrations and the frequency of its deficiency
with the severity of retinopathy.
2. Patients, Material, and Methods
2.1. Participants. This was an observational case-control
study. Study subjects were selected from a group of par-
ticipants in a study on differential characteristics of type
2 diabetic patients with (cases) and without retinopathy
(controls) in our center.The study was done at the University
Hospital Arnau de Vilanova in Lleida, Spain.This is a tertiary
referral center for ophthalmology and endocrinology in the
region. A detailed description of the study population has
been recently published [16]. From a total number of 299
subjects, we could assess a total of 283 subjects with complete
data for the currentmain study outcomes, as explained below.
We took advantage of using the previous study design to
assess the association of diabetic retinopathy and vitamin
D status in subjects without other advanced diabetic late
complications. All study subjects had normal kidney function
(calculated glomerular filtration rate > 60mL/min). By study
design, all subjects without retinopathy had normal albumin-
to-creatinine ratio (<30mg/g) and those with retinopathy
had no macroalbuminuria (albumin-to-creatinine ratio <
300mg/g). All study subjects had no known cardiovascular
complications (coronary disease, cerebrovascular disease, or
peripheral artery disease). Also, none of the patients had
a history of diabetic foot disease. We took advantage from
the design and performance of a study on quality of life
in patients with diabetic retinopathy [16]. In that study, we
included a total number of 299 type 2 diabetic subjects.
From the original study population, 16 patients could not
be included because of the following reasons: 2 patients
did not accept biobanking of blood samples at recruitment,
serum samples were not available from 8 additional subjects,
and 6 were not included because they were taking oral
supplements containing vitamin D and/or calcium. Thus, a
final number of 139 patients with retinopathy and 144 without
this complication were included. All subjects underwent a
complete clinical and laboratory evaluation.
2.2. Methods. Demographic and clinical data relevant to the
proper conduct of the present study were recorded and are
shown in Table 1. Blood pressure was measured in the sitting
position after resting for 10 minutes using a blood pres-
sure monitor (HEM-7001E, Omron, Spain). Hypertension
or dyslipidemia were considered present when the patient
was being treated with antihypertensive or lipid-lowering
drugs, respectively. Weight and height were measured by
standardized methods, and the body mass index was then
calculated (expressed as kg/m2).
Blood and spot urine samples were obtained from all par-
ticipants in the fasting state. Standard laboratory procedures
were used to determine the basic blood and urine biochem-
istry variables on a Hitachi Modular DDPP analyzer (Roche
Diagnostics, Indianapolis, USA). Glycated hemoglobin was
measured with a HPLC analyzer Variant II Turbo (Bio-RAD,
Hercules, USA). Intact parathormone was determined by
electrochemiluminescence immunoassay in an Elecsys E170
analyzer (Roche Diagnostics, Indianapolis, USA), with an
intra- and interassay variability of 2.2% and 6%, respec-
tively. Serum concentrations of 25(OH)D were measured
by a chemiluminescent microparticle immunoassay in an
Architect i2000SR analyzer (Abbott Diagnostics, Lake Forest,
USA), with an intra- and interassay variability of 2.3% and
6.2%, respectively. The date of blood testing was used to
classify the season of assessment, as follows: winter (January–
March), spring (April–June), summer (July–September), and
autumn (October–December).
An experienced ophthalmologist explored the retina
and classified the retinopathy status according to an inter-
nationally accepted classification [17]. To assess physical
activity, we used the concept of active leisure time, which
defines a sedentary person as one who spends less than
10% of his/her daily energy expenditure performing any
physical activity that requires at least 4 METs (equal or
greater physical activity expenditure than brisk walking
for 30 minutes) [18]; this allowed us to classify each sub-
ject as sedentary or active. Dietary intake of vitamin D
and calcium was measured by a validated 101-food-item
semiquantitative food frequency questionnaire (available
at http://bibliodieta.umh.es/files/2011/07/CFA101.pdf) [19].
Nutrient values for vitamin D and calcium were obtained
from food composition tables of the US Department of
Agriculture and supplemented with Spanish sources [19, 20].
The study protocol was approved by the local ethics
committee, in accordance with the Declaration of Helsinki.
All participants signed the written informed consent form.
As this is an ancillary study of our previous one, in
which only patients with relevant data were included, before
the analysis we assumed a difference of at least 3 ng/mL in
25(OH)D concentrations between patients with and without
retinopathy with a standard deviation of 8 units. The inclu-
sion of 139 with and 144 patients without retinopathy allowed
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(𝑛 = 139) 𝑝 value
Sex (male/female) 74/70 71/68 1
Non-Caucasian 5 (3.5%) 6 (4.3%) 0.95
Age (yr) 58.1 (10.3) 60.3 (8.9) 0.09
Disease duration (yr) 7.2 (5.5) 13.9 (9.3) <0.01
Insulin treatment (with or without oral agents) 17 74 <0.01
Smoking (current/past/never) 30/49/64 28/41/70 0.61
Hypolipidemic treatment 65 (45.1%) 66 (47.5%) 0.78
Antihypertensive treatment 68 (47.2%) 94 (67.6%) <0.01
Body mass index (kg/m2) 31.2 (5.2) 31.8 (5.4) 0.32
Hemoglobin A1c (%) 7.3 (1.2) 8.3 (1.4) <0.01
Cholesterol (mg/dL) 186.1 (37) 185.1 (36.5) 0.82
HDL cholesterol (mg/dL) 48.6 (10.9) 52.2 (15.6) 0.08
LDL cholesterol (mg/dL) 111.6 (30.9) 106.4 (30.2) 0.19
Triglycerides (mg/dL) 137.4 (82.4) 140.5 (122.7) 0.64
Serum creatinine (mg/dL) 0.8 (0.2) 0.8 (0.2) 0.83
Urinary albumin-to-creatinine ratio, (mg/g) 11 (26.2) 34.8 (52.4) <0.01
Calcium (mg/dL) 9.3 (0.4) 9.3 (0.4) 0.69
Phosphate (mg/dL) 3.5 (0.5) 3.5 (0.4) 0.38
Parathormone (pg/mL) 48.1 (18.9) 45.3 (17.0) 0.11
25(OH)D (ng/mL) 20.5 (8.1) 19.2 (10.1) 0.05
Vitamin D deficiency (25(OH)D <20 ng/mL) 73 (50.7%) 86 (61.9%) 0.07
Season of assessment (spring/summer/autumn/winter) 38/55/18/33 37/42/26/34 0.37
Physical activity (active/sedentary) 74/70 74/65 0.85
Daily dietary vitamin D intake (mg) 4.4 (2.2) 4.6 (2.5) 0.93
Daily dietary calcium intake (mg) 1176 (434) 1153 (529) 0.65
Data are mean ± standard deviation or n (%), as needed. HDL: high density lipoprotein; LDL: low density lipoprotein; 25(OH)D: 25-hydroxy-vitamin D3.
the achievement of a statistical power of 93% (beta = 0.07) to
detect such difference, using a one-sided t-test to assess the
differences with 5% of significance (alpha = 0.05). Therefore,
we were able to address the analysis of the primary outcome
with sufficient post hoc statistical power.
2.3. Statistical Analysis. Mean (and standard deviations) or
absolute and relative frequencies (in percentages) were com-
puted for quantitative or qualitative variables, respectively.
Differences between groupswere assessed bymeans ofMann-
Whitney tests or Chi-squared tests as adequate. Vitamin
D deficiency was defined for different thresholds (at each
unit from 15 to 40 pg/mL) of the serum concentrations
of 25(OH)D, and the relative risk was computed to assess
the increased risk of vitamin D deficiency in patients with
retinopathy versus those without this complication. To fur-
ther analyze the association of retinopathy with vitamin
D, linear regression models were used to assess serum
concentrations of 25(OH)D and logistic regression models
to assess vitamin D deficiency, establishing an appropriate
threshold in the serum levels for this purpose. Multivariate
regression analyses were also performed including age, sex,
race, hemoglobin A1c, creatinine, disease duration, body
mass index, hypolipidemic treatment, and physical activity
as potential predictors in addition to patient group. The final
models were obtained by applying a stepwise algorithm to
minimize Akaike’s Information Criterion. The interaction
of the patient group (DR and non-DR) with the creatinine
serum was included in the models as it was shown to be a
potential and significant predictor. A significance level of 0.05
was used. Statistical analyses were conducted with R 3.0.1
(R foundation for Statistical Computing, Vienna, Austria:
http://www.r-project.org/).
3. Results
Table 1 shows the results of the different study variables
and the differences between patients with and without
retinopathy. As previous studies that compared subjects
with and without this diabetic late complication, those with
retinopathy had longer diabetes duration, had higher glycated
hemoglobin concentrations, and were more frequently on
antihypertensive and insulin treatments. Interestingly, the
dietary intake of vitamin D and calcium was very similar
in both groups of patients. No differences were observed in
other clinical and laboratory parameters in the unadjusted
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Table 2: Multivariate analysis for the association of the status of retinopathy and 25(OH)D. The relevant parameters and 𝑝 values from
the linear and logistic regression models to evaluate the concentrations of 25(OH)D and the presence of vitamin D deficiency (defined as
25(OH)D <15 ng/mL) are shown. For qualitative variables, the category in the model is provided.The reference categories are no retinopathy,
Caucasian, Winter and sedentary for patient group, race, season, and physical activity, respectively.
Linear model 25(OH)D concentration Logistic model deficiency (25(OH)D <15 ng/mL)
Beta (SE) 𝑝 value Beta (SE) 𝑝 value
Intercept 20.52 (5.17) −0.73 (1.49)
Patient group (retinopathy) 10.36 (4.98) 0.04 −3.76 (1.44) 0.009
Creatinine 2.53 (4.25) 0.55 −1.76 (1.33) 0.19
Ethnicity (non-Caucasian) −5.07 (2.67) 0.05 1.94 (0.74) 0.009
Body mass index −0.26 (0.10) 0.009 0.08 (0.03) 0.004
Season (autumn) 3.21 (1.68) 0.05 −0.74 (0.42) 0.08
Season (spring) 5.03 (1.64) 0.002 −1.03 (0.42) 0.02
Season (summer) 8.04 (1.59) <0.00001 −2.09 (0.46) <0.00001
Physical activity (active) 2.21 (1.04) 0.03 −0.87 (0.30) 0.004
Interaction group ∗ creatinine −13.32 (6.03) 0.03 5.17 (1.77) 0.003
25(OH)D: 25-hydroxy-vitamin D3; SE: standard error.
analysis of the data. Although 25(OH)D concentrations were
lower in patients with retinopathy, this difference reached
only borderline statistical difference (𝑝 = 0.05). Additionally,
the frequency of vitamin D deficiency, defined as serum
25(OH)D below 20 ng/mL, was higher in subjects with
retinopathy, but this difference did not reach statistical signif-
icance (𝑝 = 0.07). Nevertheless, the prevalence of retinopathy
for 25(OH)D thresholds below 20mg/mL was significantly
higher (thresholds 15 to 19; 𝑝 ≤ 0.05), and the associated
relative risk of retinopathy was higher for all these thresholds
(Figure 1). For the purpose of the multivariate analysis,
a concentration of 15 ng/mL was chosen as the threshold
to define vitamin deficiency; in the previous analysis, this
threshold yielded the highest relative risk of retinopathy (RR:
1.43; 𝑝 = 0.03).
The multivariate analyses showed that there was a sig-
nificant association of retinopathy and 25(OH)D, even when
considering other variables associated with this variable.
These results were consistent when analyzing both the con-
centrations of 25(OH)D and the presence of vitamin D
deficiency, as defined by a 25(OH)D <15 ng/mL (𝑝 values
0.04 and 0.009, resp.) (Table 2). In addition to this, Caucasian
patients andphysically active patients had significantly higher
25(OH)D levels (𝑝 values 0.05 and 0.03, resp.) (Table 2)
and significantly lower vitamin D deficiency risk (𝑝 values
0.009 and 0.004, resp.). Body mass index was inversely
associated with 25(OH)D concentrations and positively
associated with vitamin D deficiency (𝑝 values 0.009 and
0.004, resp.) (Table 2). Considering winter as the reference
season associated with lower vitamin D levels (one as risk
value), the other seasonal 25(OH)D concentrations during
autumn, spring, and summer were statistically higher in the
two models (Table 2). Interestingly, creatinine concentration
interacted with the patient group (retinopathy versus no
retinopathy) in both models (𝑝 values 0.03 and 0.003). To
further illustrate this interaction (Table 3), the stratification
of creatinine concentrations by tertiles in each of the 2
study groups revealed that patients with retinopathy had






















Figure 1: Frequency of vitamin D deficiency according to different
25(OH)D thresholds for patients with and without retinopathy.
25(OH)D: 25-hydroxy-vitamin D
3
; DR: diabetic retinopathy.
frequencies of vitamin D deficiency that augmented with
increasing creatinine concentration tertiles (31.9%, 34.8%,
and 46.7%, resp.) in contrast to the frequencies observed in
the group of patients without retinopathy.
Further to the main analysis, we explored the association
of vitamin D status with the severity of retinopathy. The
distribution of subjects with retinopathy according to its
severity was as follows: grade 1: 63; grade 2: 42; grade 3:
28, and grade 4: 6. We analyzed the differences among
patientswithout retinopathy and thosewith this complication
stratified according to its severity (grade 1 versus grades 2–4).
The results of this analysis are shown in Table 4. Interestingly,
patients with advanced retinopathy (grades 2–4) were more
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Table 3: Frequency of vitamin D deficiency, defined as 25(OH)D <15 ng/mL, according to tertiles of serum creatinine concentrations in the
2 study groups.
Study group Serum creatinine concentration (mg/dL)
Tertile 1 (<0.72) Tertile 2 (0.72–0.88) Tertile 3 (>0.88)
No retinopathy 17/47 (36.2%) 12/51 (23.5%) 10/46 (21.7%)
Retinopathy 15/47 (31.9%) 16/46 (34.8%) 21/45 (46.7%)
Values are 𝑛 (%).
Table 4: Results of the analysis of serum 25(OH)D concentrations and frequency of vitamin D deficiency according to the severity of diabetic
retinopathy.
Vitamin D status No DR DR: grade 1 DR: grades 2–4 𝑝 values
𝑛 = 144 𝑛 = 63 𝑛 = 76 Grade 1 versus no DR Grades 2–4 versus no DR
25 (OH)D (ng/mL) 20.5 (8.1) 20 (9) 18.6 (11) 0.52 0.02
Vitamin D deficiency (<20 ng/dL) 73 (50.7%) 35 (55.6%) 51 (67.1%) 0.62 0.03
Data are mean ± standard deviation or 𝑛 (%), as needed. DR: diabetic retinopathy; 25(OH)D: 25-hydroxy-vitamin D3.
frequently vitamin D deficient (25(OH)D <20 ng/mL) and
had lower mean concentration of 25(OH)D compared with
type 2 diabetic patients without retinopathy (𝑝 values of
0.03 and 0.02, resp.) (Table 4). Concerning these variables,
patients with mild diabetic retinopathy (grade 1) were not
significantly different to the group without retinopathy.
4. Discussion
Our study confirms the association of vitamin D deficiency
with diabetic retinopathy in type 2 diabetes. As in previous
reports, type 2 diabetic patients with retinopathy had lower
serum 25(OH)D concentrations. Furthermore, a higher pro-
portion of vitamin D deficiency was confirmed in subjects
carrying this microvascular complication. In addition to
this, there was an increased risk of retinopathy in those
with severe vitamin D deficiency (RR = 1.43, 𝑝 = 0.03),
with this association being even more significant in the
adjusted model that included the interaction of retinopathy
with creatinine (𝑝 = 0.009). Concerning the severity of
diabetic retinopathy, patients with more advanced stages of
retinopathy had lower concentrations of 25(OH)D and were
more frequently vitamin D deficient.
This is the first study to address the potential relationship
of vitamin D status with diabetic retinopathy in type 2
diabetes in Europe. Previous publications analyzed the data
according to differences in 25(OH)D concentrations between
groups or, alternatively, as the prevalence of retinopathy
according to a given 25(OH)D threshold to define deficiency
of this vitamin. An initial study on 66 Turkish type 2 diabetic
subjects (46 with retinopathy) found no differences in serum
25(OH)D between type 2 diabetic patients according to the
presence or absence of retinopathy and also to the severity
of retinopathy [7]. In contrast, Suzuki et al. showed that
Japanese type 2 diabetic patients with proliferative retinopa-
thy had lower serum 25(OH)D [8]. Also, the first study
carried out in the USA revealed an association of 25(OH)D
concentrations with the severity of diabetic retinopathy [9].
However, the only population-based study on this matter,
performed also in the USA, could not demonstrate an
association between retinopathy and serum 25(OH)D con-
centration; these authors only found a greater prevalence of
vitamin D deficiency with increased severity of retinopathy
[10]. In Lebanese type 2 diabetic patients with retinopathy,
lower concentrations of 25(OH)D were also found; addition-
ally, vitamin D was an independent predictor of retinopathy
[11]. A very recent Chinese study, with the largest number
of patients with diabetic retinopathy included in a single
study so far, revealed an independent association between
25(OH)D concentrations and diabetic retinopathy, especially
for advanced sight-threatening retinopathy [12]. This study
found a twofold increase in sight-threatening retinopathy
among subjects with serum 25(OH)D below 15.57 ng/mL. A
recent large, population-based, cross-sectional study inKorea
confirmed that there is an inverse relationship of 25(OH)D
concentrations with the presence of any retinopathy and
also with proliferative retinopathy [13]. This study did not
provide details on the type of diabetes of the included
subjects. Thus, most of the reports were able to identify an
association between 25(OH)D and retinopathy or its defi-
ciency. Additionally, those studies that performed a detailed
characterization of the severity of retinopathy revealed that
proliferative or advanced retinopathy grades were clearly
associated with 25(OH)D and/or its deficiency [9, 10, 12, 13].
It should be noted that the few available studies on this issue
in type 1 diabetes show conflicting data [14, 15]. In summary,
our results are discordant with 2 previous studies that did not
show an association of vitamin D with diabetic retinopathy
in type 2 diabetes [7, 10]. In contrast, our findings are in line
with the majority of previous reports that demonstrated that
vitamin D status is associated with the presence of diabetic
retinopathy [9, 11–13]. Additionally, it is remarkable that, as in
our study, most others have found an association of vitamin
D status and the severity of retinopathy [9–13].
Our study shares the most important limitation with
previous studies; that is, all of themwere cross-sectional.This
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design allows only for the identification of an association
between study variables. To our knowledge, there is no
prospective follow-up study in type 2 diabetes and the only
one available in type 1 diabetes did not identify vitamin D
as a factor involved in the development of retinopathy [4].
Thus, the question on the potential role of vitamin D in the
pathogenesis of diabetic retinopathy has not been answered
yet. Another limitation resides on the fact that only one
of the previous studies can be considered as population-
based; thus, the external validity of the findings of all other
reports, including ours, is clearly limited. Although subjects
included in our study may not be fully representative of
the background population, the clinical characteristics of
patients in our study are very similar to those of recently
published population-based cohorts in our region [21].
Another limitation of our study is that we did not deter-
mine the time of sun exposure. This limitation is also shared
with most previous studies, except for the one by Ahmadieh
et al. who used a questionnaire to assess the time spent
outdoors [11]. Physical activity may be used as a surrogate of
sun exposure as most of this activity is performed outdoors.
Thus, we used this measure as an additional variable in the
multivariate analysis that revealed that this was a variable
with an influence on vitamin D status. Therefore, future
studies should include a measure of sun exposure as an
essential contributor to 25(OH)D concentrations.
We should point out that none of the subjects in the
current study had advanced renal disease and/or impairment.
It must be pointed out that renal disease in diabetes could
contribute as an important confounder of vitamin D status
[1, 22]. Some of the previous studies either did not provide
information on renal function or included patients with
advanced renal disease. Our findings concerning the strong
interaction of serum creatinine and the retinopathy status
should be taken into consideration in future studies. The
careful revision of the previous publications on this matter
confirmed that only the American population-based study
by Patrick et al. included creatinine as a potential important
confounder in the analysis of the association of 25(OH)D and
retinopathy.
Besides, an association between vitamin D and cardio-
vascular disease has been previously described [21], also in
type 2 diabetes [23]. The presence of macrovascular disease
in patients with type 2 diabetes may be a confounding factor
when assessing an association of vitamin D with other con-
ditions. In our study, the presence of clinical cardiovascular
disease was an exclusion criterion. However, the potential
effect of the presence of atherosclerotic disease was not
controlled for in any of the previous studies. Four of them did
not provide information on the presence of cardiovascular
disease [7, 8, 10, 11], and the other 2 included a significant
proportion of patients with cardiovascular disease [9, 12].The
exclusion of this complication in our study clearly avoided
the potential association of vitamin D with cardiovascular
disease as a confounding variable. In conclusion, an impor-
tant strength of the current study is that the patients included
did not have important confounding conditions that have
an important influence on vitamin D concentrations, that is,
renal insufficiency and cardiovascular disease.
5. Conclusion
Our study confirms the association of a higher frequency of
vitamin D deficiency and lower concentrations of 25(OH)D
with diabetic retinopathy in patients with type 2 diabetes.
Further, these parameters of poor vitamin D status are
also associated with the severity of diabetic retinopathy.
These findings reveal the potential role of vitamin D in the
pathogenesis of diabetic retinopathy. However, we are in
great need of well-designed prospective observational studies
sufficiently powered to test the role of vitamin D status in
the development of diabetic retinopathy and other diabetic
microvascular complications.
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